Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like OpGen Earns CE Mark for COVID-19 Diagnostic August 20, 2020 Russian COVID-19 Therapeutic Coronavir to Hit Pharmacy Shelves in Coming Days September 20, 2020 OIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process April 7, 2016